Human herpesvirus-6B protein U19 contains a p53 BOX I homology motif for HDM2 binding and p53 stabilization

Virology

Volumn 448, Issue , 2014, Pages 33-42

  Kofod Olsen, Emil ^a,c   Pettersson, Susanne ^b,d   Wallace, Maura ^b   Abduljabar, Ahmed Basim ^a   Øster, Bodil ^a,d,e   Hupp, Ted ^b   Höllsberg, Per ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF SKÖVDE   (Sweden)

^e CLC Bio   (Denmark)

Author keywords

HDM2; Human herpesvirus 6B; P53; U19; Virus cell interactions

Indexed keywords

PROTEIN MDM2; PROTEIN P53; U19 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HUMAN HERPESVIRUS 6; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; UBIQUITINATION; UPREGULATION;

EID: 84886303984     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.10.002     Document Type: Article

References (38)

1. Brattain M.G., Fine W.D., Khaled F.M., Thompson J., Brattain D.E. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Research 1981, 41:1751-1756.
2. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998, 282:1497-1501.
3. Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M.B., Siliciano J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998, 281:1677-1679.
4. Casavant N.C., Luo M.H., Rosenke K., Winegardner T., Zurawska A., Fortunato E.A. Potential role for p53 in the permissive life cycle of human cytomegalovirus. Journal of Virology 2006, 80:8390-8401.
5. Chen Z., Knutson E., Wang S., Martinez L.A., Albrecht T. Stabilization of p53 in human cytomegalovirus-initiated cells is associated with sequestration of HDM2 and decreased p53 ubiquitination. Journal of Biological Chemistry 2007, 282:29284-29295.
6. Collot-Teixeira S., Bass J., Denis F., Ranger-Rogez S. Human tumor suppressor p53 and DNA viruses. Reviews in Medical Virology 2004, 14:301-319.
7. Hannemann H., Rosenke K., O'Dowd J.M., Fortunato E.A. The presence of p53 influences the expression of multiple human cytomegalovirus genes at early times postinfection. Journal of Virology 2009, 83:4316-4325.
8. Kashanchi F., Araujo J., Doniger J., Muralidhar S., Hoch R., Khleif S., Mendelson E., Thompson J., Azumi N., Brady J.N., Luppi M., Torelli G., Rosenthal L.J. Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53. Oncogene 1997, 14:359-367.
9. Kofod-Olsen E., Møller J.M., Schleimann M.H., Bundgaard B., Bak R.O., Øster B., Mikkelsen J.G., Hupp T., Höllsberg P. Inhibition of p53-dependent, but not p53-independent, cell death by U19 protein from human herpesvirus 6B. PLoS One 2013, 8:e59223.
10. Kofod-Olsen E., Ross-Hansen K., Mikkelsen J.G., Höllsberg P. Human herpesvirus 6B U19 protein is a PML-regulated transcriptional activator that localizes to nuclear foci in a PML-independent manner. Journal of General Virology 2008, 89:106-116.
11. Kovacs A., Weber M.L., Burns L.J., Jacob H.S., Vercellotti G.M. Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. American Journal of Pathology 1996, 149:1531-1539.
12. Kubbutat M.H., Ludwig R.L., Ashcroft M., Vousden K.H. Regulation of Mdm2-directed degradation by the C terminus of p53. Molecular and Cellular Biology 1998, 18:5690-5698.
13. Kussie P.H., Gorina S., Marechal V., Elenbaas B., Moreau J., Levine A.J., Pavletich N.P. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 1996, 274:948-953.
14. Lacroix A., Collot-Teixeira S., Mardivirin L., Jaccard A., Petit B., Piguet C., Sturtz F., Preux P.M., Bordessoule D., Ranger-Rogez S. Involvement of human herpesvirus-6 variant B in classic Hodgkin's lymphoma via DR7 oncoprotein. Clinical Cancer Research 2010, 16:4711-4721.
15. Lacroix A., Jaccard A., Rouzioux C., Piguet C., Petit B., Bordessoule D., Ranger-Rogez S. HHV-6 and EBV DNA quantitation in lymph nodes of 86 patients with Hodgkin's lymphoma. Journal of Medical Virology 2007, 79:1349-1356.
16. Li M., Brooks C.L., Wu-Baer F., Chen D., Baer R., Gu W. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003, 302:1972-1975.
17. Lilley C.E., Chaurushiya M.S., Weitzman M.D. Chromatin at the intersection of viral infection and DNA damage. Biochimica et Biophysica Acta 2010, 1799:319-327.
18. Okuno T., Takahashi K., Balachandra K., Shiraki K., Yamanishi K., Takahashi M., Baba K. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. Journal of Clinical Microbiology 1989, 27:651-653.
19. Schleimann M.H., Møller J.M., Kofod-Olsen E., Höllsberg P. Direct Repeat 6 from human herpesvirus-6B encodes a nuclear protein that forms a complex with the viral DNA processivity factor p41. PLoS ONE 2009, 4:e7457.
20. Shangary S., Wang S. Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy. Annual Review of Pharmacology and Toxicology 2009, 49:223-241.
21. Shieh S.Y., Ahn J., Tamai K., Taya Y., Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes & Development 2000, 14:289-300.
22. Shimizu H., Burch L.R., Smith A.J., Dornan D., Wallace M., Ball K.L., Hupp T.R. The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo. Journal of Biological Chemistry 2002, 277:28446-28458.
23. Takemoto M., Koike M., Mori Y., Yonemoto S., Sasamoto Y., Kondo K., Uchiyama Y., Yamanishi K. Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion. Journal of Virology 2005, 79:13037-13046.
24. Takemoto M., Mori Y., Ueda K., Kondo K., Yamanishi K. Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. Journal of General Virology 2004, 85:869-879.
25. Tsao E.H., Kellam P., Sin C.S., Rasaiyaah J., Griffiths P.D., Clark D.A. Microarray-based determination of the lytic cascade of human herpesvirus 6B. The Journal of General Virology 2009, 90:2581-2591.
26. Turcanova V.L., Bundgaard B., Höllsberg P. Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigen. Journal of Clinical Virology 2009, 46:15-19.
27. Vassilev L.T., Vu B.T., Graves B., Carvajal D., Podlaski F., Filipovic Z., Kong N., Kammlott U., Lukacs C., Klein C., Fotouhi N., Liu E.A. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004, 303:844-848.
28. Vousden K.H., Lane D.P. p53 in health and disease. Nature Reviews Molecular Cell Biology 2007, 8:275-283.
29. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
30. Wallace M., Worrall E., Pettersson S., Hupp T.R., Ball K.L. Dual-site regulation of MDM2 E3-ubiquitin ligase activity. Molecular Cell 2006, 23:251-263.
31. Wang J., Belcher J.D., Marker P.H., Wilcken D.E., Vercellotti G.M., Wang X.L. Cytomegalovirus inhibits p53 nuclear localization signal function. Journal of Molecular Medicine (Berlin) 2001, 78:642-647.
32. Wang J., Marker P.H., Belcher J.D., Wilcken D.E., Burns L.J., Vercellotti G.M., Wang X.L. Human cytomegalovirus immediate early proteins upregulate endothelial p53 function. FEBS Letters 2000, 474:213-216.
33. Ward K.N., Gray J.J., Fotheringham M.W., Sheldon M.J. IgG antibodies to human herpesvirus-6 in young children: changes in avidity of antibody correlate with time after infection. Journal of Medical Virology 1993, 39:131-138.
34. Yamanishi K., Okuno T., Shiraki K., Takahashi M., Kondo T., Asano Y., Kurata T. Identification of human herpesvirus-6as a causal agent for exanthem subitum. Lancet 1988, 1:1065-1067.
35. Zhang Z., Evers D.L., McCarville J.F., Dantonel J.C., Huong S.M., Huang E.S. Evidence that the human cytomegalovirus IE2-86 protein binds mdm2 and facilitates mdm2 degradation. Journal of Virology 2006, 80:3833-3843.
36. Øster B., Bundgaard B., Höllsberg P. Human herpesvirus 6B induces cell cycle arrest concomitant with p53 phosphorylation and accumulation in T cells. Journal of Virology 2005, 79:1961-1965.
37. Øster B., Höllsberg P. Viral gene expression patterns in human herpesvirus 6B-infected T cells. Journal of Virology 2002, 76:7578-7586.
38. Øster B., Kofod-Olsen E., Bundgaard B., Höllsberg P. Restriction of human herpesvirus 6B replication by p53. Journal of General Virology 2008, 89:1106-1113.